Jun 23, 2015 PharmaCyte Biotech Enters Into Research and Consulting Agreements With University of Technology Sydney
Jun 18, 2015 PharmaCyte Biotech's Dr. Mark Rabe Discusses the Significance of Schedule 1 License to Company's Future in Cannabis Research
Jun 16, 2015 PharmaCyte Biotech Showcasing Technology and Treatments at 2015 BIO International Convention
Jun 9, 2015 PharmaCyte Biotech’s Contract Research Organization Voted Australia’s Favorite CRO for 2015
Jun 3, 2015 PharmaCyte Biotech's Cancer Treatment Shows "Complete Tumor Remission" in Published Preclinical Study
